|
PRPH
|
ProPhase Labs, Inc.
|
US
|
NASDAQ
|
|
PRTK
|
Paratek Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PRTT
|
Protect Pharmaceutical Corp
|
US
|
OTC
|
|
PRVB
|
Provention Bio, Inc.
|
US
|
NASDAQ
|
|
PULM
|
Pulmatrix, Inc.
|
US
|
NASDAQ
|
|
PVCT
|
Provectus Pharma
|
US
|
OTC
|
|
PXS
|
Pharmaxis Ltd.
|
AU
|
ASX
|
|
PYFA
|
Pyridam Farma Tbk
|
ID
|
JK
|
|
R2WA
|
BEXIMCO PHARMA.GDR REGS 1
|
DE
|
F
|
|
R5XA
|
ACELRX PHARMACEUT. DL-01
|
DE
|
F
|
|
RAPP
|
Rapport Therapeutics, Inc. Common Stock
|
US
|
US
|
|
RCE
|
Recce Ltd
|
AU
|
ASX
|
|
RCPIQ
|
Rock Creek Pharmaceuticals Inc
|
US
|
OTC
|
|
RDHL
|
Redhill Biopharma Ltd.
|
US
|
NASDAQ
|
|
RDY
|
Dr. Reddy's Laboratories Ltd
|
US
|
NYSE
|
|
REDX
|
Redx Pharma Plc
|
UK
|
LSE
|
|
REKA
|
Rekah Pharmaceutical Industry Ltd
|
IL
|
TA
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
US
|
NASDAQ
|
|
RHHBY
|
Roche Hldg Ltd Spons
|
US
|
OTC
|
|
RLMD
|
Relmada Therapeutics, Inc.
|
US
|
NASDAQ
|